Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis

Breast Cancer Research and Treatment

Volumn 39, Issue 2, 1996, Pages 213-220

  Lönn, Ulf ^a   Lönn, Sigrid ^a   Nilsson, Bo ^a   Stenkvist, Björn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; c erb B2; Fine needle biopsies; Gene amplification

Indexed keywords

LIQUID NITROGEN; METHANOL; PROGESTERONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CRYOPRESERVATION; CYTOLOGY; FEMALE; GENE AMPLIFICATION; GENE NUMBER; HUMAN; HUMAN TISSUE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; ONCOGENE C ERB; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029810425     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806188     Document Type: Article

References (23)

1. Fisher B, Slack N, Katrych D: Ten-year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140: 528-534, 1975
2. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Cancer 41: 1170-1178, 1978
3. Haagensen CD: Treatment of curable carcinoma of the breast. Int J Radial Oncol Biol Phys 2: 975-980, 1977
4. Nemoto T, Vana J, Bedwani RN et al.: Management and survival of female breast cancer. Cancer 45: 2917-2924, 1980
5. Stenkvist B, Bengtsson E, Dahlqvist B, Eklund G, Eriksson O, Jarkrans T, Nordin B: Predicting breast cancer recurrence. Cancer 50: 2884-2893, 1982
6. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
7. Escot C, Theillet C, Lidereau R, Spyratos F, Champene M, Gest J, Callahan R: Genetic alterations of the c-myc protooncogene (MYC) in human primary breast carcinoma. Proc Natl Acad Sci (USA) 83: 4834-4838, 1986
8. Ali IU, Merlo G, Callahan R, Lidereau R: The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails bcl-1, int-2 and hst loci. Oncogene 4: 89-92, 1989
9. Hynes N: Amplification and overexpression of the erbB2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Seminars in Cancer Biology 4: 19-26, 1993
10. Perren T: c-erb-B2 oncogene as a prognostic marker in breast cancer. Br J Cancer 63: 328-332, 1991
11. Lönn U, Lönn S, Nylen U, Stenkvist B: Appearance and detection of multiple copies of the mdr-1 gene in clinical samples of mammary carcinoma. Int J Cancer 51: 682-686, 1992
12. Lönn U, Lönn S, Nylen U, Stenkvist B, Vennström B: Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction. Breast Cancer Research and Treatment 23: 191-200, 1992
13. Franzen S, Zajizek J: Aspiration biopsy in diagnosis of palpable lesions of the breast. Acta Radiol 7: 241-262, 1968
14. Stenkvist B, Westman-Naeser S, Holmqvist J, Nordin B, Bengtsson E, Vegelius J, Eriksson O, Fox C: Computerized nuclear morphometry as an objective method for characterizing human cancer cell populations. Cancer Res 38: 4688-4697. 1978
15. Tal M, King C, Kraus M, Ullrich A, Schlessinger J, Givol D: Human HER-2 (neu) promotor: Evidence for multiple mechanisms for transcription initiation. Mol Cell Biol 7: 2597-2601, 1987
16. Flemington E, Bradshaw H, Traina-Dorge V, Slagel V, Deininger P: Sequence, structure and promoter characterization of the human thymidine kinase gene. Gene 52: 267-277, 1987
17. Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S, Mantel N, McPherson K, Peto J, Smith P: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1-39, 1977
18. Cox DR: Regression models and life-tables. J Roy Stat Soc B 34: 187-200, 1972
19. Frye R, Benz C, Liu E: Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 4: 1153-1157, 1989
20. Noonan K, Beck C, Holzmayer et al.: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci (USA) 87: 7160-7164, 1990
21. Crabbe D, Peters J, Seeger RC: Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagnostic Molecular Pathology 1: 229-234, 1992
22. Gusterson B, Gelber R, Goldhirsch et al.: Prognostic importance of c-erb-B2 expression in breast cancer. J Clin Oncol 10: 1049-1056, 1992
23. van de Vijver M: Molecular genetic changes in human breast cancer. Advances in Cancer Res 61: 25-56, 1993